On Jan. 11, 65, Channel News Asia reported Merck, the US pharmaceutical company. Announcing the effectiveness of pills against COVID-19 Molnupiravir can fight COVID-19 New species, Omicron, including COVID-19 other species
“We are very confident that molnupiravir will be effective in the fight against Omicron. Molecular mechanisms of the drug will be able to work in omicron resistance. And I imagine the drug will also be able to fight other strains of coronavirus,” Dean Lee, president of Merck Research Laboratories. The efficacy of molnupiravir was discussed at the JP Morgan Annual Healthcare Conference.
Merck’s latest efficacy data for molnupiravir was published in Nov. 64. Data on the effect of molnupiravir in Anti-Covid Omicron But from the data of 1,433 COVID-19 patients, it was found that molnupiravir It can reduce the number of people who need to be hospitalized and die by 30%.
However, the efficacy of molnupiravir in the fight against omikron must be regarded as diminished. because before Molnupiravir has been shown to reduce the number of severe cases and deaths by 50%. Several countries around the world, including the US Food and Drug Administration, the UK, Japan and India have approved it. Take pills against COVID-19 mole nupiravir Several countries have also entered into agreements to purchase the drug from Merck, while India also sells molnupiravir tablets. in pharmacies across the country so that people can buy and eat.
